Skip to main content
Sign In
 

Gastroenterology, Hepatology and Nutrition - Research Funding


 

(listed alphabetically by Principal Investigator or by Section faculty member involved)

Determination of Pathogenetic Mechanisms of Eosinophilic Esophagitis
Principal Investigator: Glenn T. Furuta, MD
Source: CURED (Campaign Urging Research for Eosinophilic Disease) Foundation
Amount: $100,000/yr
Term: 2008 - 2009

Esophageal Fibrosis in Patients with Eosinophilic Esophagitis
Principal Investigators: Glenn T. Furuta, MD, and Steven J. Ackerman, PhD
Source: American Gastroenterological Association
Amount: $100,000/yr
Term: 2008 - 2010

Improving Lives of Patients with Eosinophilic Esophagitis
Principal Investigators: Glenn T. Furuta, MD, Rachel Rosen, MD, and Samuel Nurko, MD
Source: Pappas Foundation
Amount: $60,000
Term: 2006 - 2009

The International Gastrointestinal Eosinophil Research Consortium
Principal Investigator: Glenn T. Furuta, MD
Source: Food Allergy Project
Amount: $330,000/yr
Term: 2008 - 2011

Natural History of Eosinophilic Esophagitis
Principal Investigator: Glenn T. Furuta, MD
Source: Pappas Foundation
Amount: $20,000/yr
Term: 2009

Novel Assessment of Esophageal Disease
Principal Investigators: Glenn T. Furuta, MD, and Steven J. Ackerman, PhD
Source: NIAID, NIH - R21-AI079925
Amount: $125,000/yr
Term: 2008 - 2010

Role of Eosinophils in Esophageal Dysfunction
Principal Investigator: Glenn T. Furuta, MD
Source: NIDDK, NIH - 7 R01 DK062245-03
Amount: $312,422/yr
Term: 2004 - 2009

Autism Treatment Network
Principal Investigator: Ann M. Reynolds, MD
Co-Investigator: Glenn T. Furuta, MD
Source: Autism Treatment Network
Amount: $3,400/yr
Term: 2008 - 2009

A Multicenter, Double-Blind Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Crohn’s Disease
Principal Investigator: Edward J. Hoffenberg, MD
Source: Abbott Laboratories
Amount: Per patient
Term: 2008 - ongoing

A Multicenter, Prospective, Long-Term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease
Principal Investigator: Edward J. Hoffenberg, MD
Source: Johnson & Johnson
Amount: Per patient
Term: 2008 - ongoing

Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Co-Investigators: Edward J. Hoffenberg, MD, and Ronald J. Sokol, MD
Source: NIH - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002 - 2006

Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: NIH - 1 U19 AI50864-01 (Revised)
Amount: $2,679,247
Term: 2001 - 2006

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2004 - 2006

An Efficacy and Safety Study of Reslizumab (CTX55700) in the Treatment of Eosinophilic Esophagitis in Subjects Aged 5 to 18 years
Principal Investigator: Robert E. Kramer, MD
Source: Ception Therapeutics, Inc
Amount: $10,396/yr
Term: 2008 - 2010

Altering the PL of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: NIDDK, NIH - K08 DK064605-01
Amount: $118,950/yr
Term: 2003 - 2008

Autoimmunity Prevention Centers Pilot Project Award
Principal Investigator: Edwin Liu, MD
Source: NIH Autoimmunity Prevention Center
Amount: $75,000/yr
Term: 2007 - 2008

Autoimmunity Prevention Center U-01 Pilot Award
Consultant: Edwin Liu, MD
Source: NIH Autoimmunity Prevention Center
Amount: $25,000/yr
Term: 2007 - 2008

Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - K08 DK60710-01
Amount: $625,000
Term: 2002 - 2006

Investigation of Pathogenic Autoreactive T Cells in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: American Liver Foundation - PN200509-244
Amount: $100,000
Term: 2006 - 2008

Perturbation of Regulatory T Cells in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: American Gastroenterolgical Association
Amount: $25,000/yr
Term: 2008 - 2009

Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: March of Dimes Birth Defects Foundation
Amount: $150,000
Term: 2005 - 2007

Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - RO3 DK069818-01
Amount: $100,000
Term: 2004 - 2006

T Cell-Mediated Mechanisms of Autoimmunity in Murine and Human Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - 1 R01 DK078195-01A1
Amount: $272,953
Term: 2007 - 2012

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Vincent Mukkada, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2005 - 2007

Longitudinal Study of Cystic Fibrosis-Associated Liver Disease
Principal Investigator: Michael R. Narkewicz, MD
Source: Cystic Fibrosis Foundation
Amount: $500,000/yr
Term: 2008 - 2009

Long-Term Follow-Up Protocol to Assess Pediatric Subjects After Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001 - 2007

A Multicenter Group to Study Acute Liver Failure in Children
Principal Investigator: Robert Squires, MD
Co-Investigators: Michael R. Narkewicz, MD, and Ronald J. Sokol, MD
Source: NIDDK, NIH - U01 DK072146-01
Amount: $25,000/yr (Denver)
Term: 2005 - 2010

Pegylated Interferon +/- Ribavirin for Children with HCV: Randomized Placebo-Controlled Trial of Pegylated Interferon With or Without Ribavirin
Principal Investigator: Kathleen Schwarz, MD
Investigator: Michael R. Narkewicz, MD
Source: NIDDK, NIH - U01 DK067767
Amount: $18,000/yr (Denver)
Term: 2004 - 2010

Studies of Pediatric Liver Transplantation
Principal Investigator: Anne Lindblad, PhD
Co-Investigators: Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, and Ronald J. Sokol, MD
Source: NIDDKD, NIH - 1 U01 DK061693-01A1
Amount: $940,000/yr
Term: 2004 - 2009

Study of a New Method of Assessment of Fat Malabsorption in Cystic Fibrosis
Principal Investigator: James Heubi, MD (Cincinnati)
Investigator: Michael R. Narkewicz, MD
Source: Cystic Fibrosis Foundation
Amount: $15,000/yr
Term: 2007 - 2008

Pediatric Intestinal Failure Consortium
Principal Investigator: Robert Squires, MD
Investigator: Jason Soden, MD
Source: NIDDK, NIH
Amount: $5,428
Term: 2008 - 2009

Cholestatic Liver Disease Consortium Support
Principal Investigator: Ronald J. Sokol, MD
Source: Alpha One Foundation
Amount: $50,000/yr
Term: 2006 - 2011

Colorado Clinical and Translational Sciences Institute
Principal Investigator: Ronald J. Sokol, MD
Co-Directors: William W. Hay, Jr., MD, Michael G. Kahn, MD, PhD, Robert H. Eckel, MD, Mark W. Geraci, MD, Marc Moss, MD, and Andrew Kramer, MD
Source: NCRR, NIH - UL1 RR025780, KL1RR025779, TL1 RR025778
Amount: $76,155,655
Term: 2008 - 2013

Pediatric Clinical Translational Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Directors: William W. Hay, Jr., MD, and Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: NCRR, NIH - MO1 RR00069
Amount: $19,434,966
Term: 2006 - 2008

Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Co-Investigators: Cara L. Mack, MD, Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, Frederick Karrer, MD, and Mark Lovell, MD
Source: NIDDK, NIH - 1 U01-DK062453
Amount: $486,984/yr
Term: 2002 - 2009

Institutional Training Grant - Pediatric Gastroenterology
Principal Investigator: Ronald J. Sokol, MD
Co-Investigator: Michael R. Narkewicz, MD
Source: NIDDKD, NIH - 1 T32 DK067009-01
Amount: $243,825/yr
Term: 2005 - 2010

Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: NIH - DK38446-09
Amount: $1,595,198
Term: 2001 - 2006

Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Co-Investigators: Cara L. Mack, MD, Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, and Johan L. Van Hove, MD, PhD
Source: NIDDK, NCRR, ORD, NIH - 1 U54 DK 078377
Amount: $728,251/yr
Term: 2004 - 2009

Supply Agreement with Mead Johnson Nutritionals, Inc., for Pregestamil Infant Formula for 140 Infants in Biliary Atresia Research Consortium Study, Steroids in Biliary Atresia Randomized Trial
Principal Investigator: Ronald J. Sokol, MD
Source: Mead Johnson Nutritionals, Inc.
Amount: $10,000/yr
Term: 2005 - 2009

Functional Outcomes in Pediatric Liver Transplantation
Principal Investigator: Estella Alonso, MD
Co-Investigator: Ronald J. Sokol, MD
Source: NICHD, NIH - 1 R01 HD045694
Amount: $421,088/yr
Term: 2005 - 2010

First- and Second-Year Clinical Fellowship (Jillian Sullivan, MD)
Principal Investigator: Jillian Sullivan, MD
Source: Cystic Fibrosis Foundation
Amount: $47,000/yr
Term: 2008 - 2010

Isoprostanes: A Marker of Oxidative Injury in Non-Alcoholic Fatty Liver
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: TCH Research Institute Pilot Award
Amount: $36,000/yr
Term: 2008 - 2009

Isoprostanes: A Marker of Oxidative Injury in Non-Alcoholic Fatty Liver
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: TCH CTRC Pilot and Feasibility Award
Amount: $25,000/yr
Term: 2008 - 2009

Studies of Primary Sclerosing Cholangitis (STOP-SC)
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: Morgan Foundation
Amount: $10,000/yr
Term: 2008 - 2013

First- and Second-Year Clinical Fellowship (Christine Waasdorp, MD)
Principal Investigator: Christine Waasdorp, MD
Source: Cystic Fibrosis Foundation - WAASDO07B0
Amount: $91,750
Term: 2007 - 2009

First- and Second-Year Clinical Fellowship (Samantha Woodruff, MD)
Principal Investigator: Samantha Woodruff, MD
Source: Cystic Fibrosis Foundation - WOODRU06B0
Amount: $85,250
Term: 2006 - 2008

Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: Adria A. Condino, DO
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2005

Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: John Whitworth, MD
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2006

Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - 1 U19 AI50864-01 (Revised)
Amount: $2,679,247
Term: 2001-2006

Pediatric Clinical Translational Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Director: William W. Hay, Jr., MD
Associate Program Director: Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: National Institutes of Health, National Center for Research Resources - MO1 RR00069
Amount: $16,884,197
Term: 2001-2006

Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005

Altering the Pl of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: National Institutes of Health - K08 DK064605-01
Amount: $610,490
Term: 2003-2008

Defining the Potential Role of Costimulation by Enterocytes in Celiac Disease
Principal Investigator: Edwin Liu, MD
Source: GlaxoSmithKline and Institute of Digestive Health GIDH Basic Research Award
Amount: $50,000
Term: 2000-2005

Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - K08 DK60710-01
Amount: $625,000
Term: 2002-2006

Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO3 DK069818-01
Amount: $100,000
Term: 2004-2006

Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: March of Dimes Birth Defects Foundation
Amount: $150,000
Term: 2005-2007

Long-Term Follow-Up Protocol to Assess Pediatric Subjects after Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001-2007

Pegylated Interferon +/- Ribavirin for Children with HCV
Principal Investigator: Kathy Schwarz, MD
MultiCenter Trial Principal Investigator (Denver): Michael R. Narkewicz, MD
Source: National Institutes of Health - U01 DK067767
Amount: $18,000/yr (Denver)
Term: 2004-2009

Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002-2006

Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U54 RR019455
Amount: $3,750,000
Term: 2004-2009

Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,595,198
Term: 2001-2006

Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 UO1-DK062453-01
Amount: $1,586,366
Term: 2002-2009

A Preliminary Clinical Research Study on Antioxidant Therapy for Biliary Atresia in Infants and Children
Principal Investigator: Ronald J. Sokol, MD
Source: Madigan Foundation
Amount: $22,750
Term: 2002-2005

Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U01 DK061693
Amount: $4,700,000
Term: 2004-2009

A Multicenter Group to Study Acute Liver Failure in Children
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U01 DK072146
Amount: $25,000/yr
Term: 2005-2010

Functional Outcomes in Pediatric Liver Transplantation
Principal Investigator: Robert Squires, MD
Local Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - R01 HD045694
Amount: $2,247,040
Term: 2005-2010

Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: Fugisawa, Roche Laboratories
Amount: $4,000/yr
Term: 1995-present

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jason S. Soden, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2003-2005

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2004-2006

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Vincent Mukkada, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2005-2007

Institutional Training Grant - Pediatric Gastroenterology
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 T32 DK06709
Amount: $1,082,424
Term: 2005

Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: Adria A. Condino, DO
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2005

Regulation of Biliary Secretion by Purinergic Signaling
Principal Investigator: Andrew P. Feranchak, MD
Source: National Institutes of Health - K08 DK61480
Amount: $653,400
Term: 2002-2007

Calcium-Dependent Secretion In Biliary Epithelium
Principal Investigator: Andrew P. Feranchak, MD
Source: Cystic Fibrosis Foundation
Amount: $64,695
Term: 2004-2005

Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - 1 U19 AI50864-01
Amount: $2,679,247
Term: 2001-2006

Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PHD, MPH
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002-2006

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane A. Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2004-2006

Altering the Pl of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: National Institutes of Health - K08 DK064605-01
Amount: $610,490
Term: 2003-2008

Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - K08 DK60710-01
Amount: $625,000
Term: 2002-2006

Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health - R03 DK069818-01
Amount: $100,000
Term: 2004-2006

Long-Term Follow-Up Protocol to Assess Pediatric Subjects after Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001-2007

Pegylated Interferon +/- Ribavirin for Children with HCV (Multicenter Trial)
Principal Investigator: Kathy Schwarz, MD
Co-Principal Investigator: Michael R. Narkewicz, MD
Source: National Institutes of Health - U01 DK067767
Amount: $18,000/yr
Term: 2004-2009

Evaluation of Infantile Gastroesophageal Reflux Utilizing pH-Impedance Monitoring
Principal Investigator: Judith A. O'Connor, MD
Source: Pediatric General Clinical Research Center, National Center for Research Resources, National Institutes of Health - M01-RR00069
Term: 2003-2005

Frequency of ASCA Seropositivity in Children with Cystic Fibrosis
Principal Investigator: Judith A. O'Connor, MD
Source: General Clinical Research Center, National Center for Research Resources, National Institutes of Health - M01-RR00069
Term: 2003-2004

Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jason S. Soden, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2003-2005

Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Co-Investigator: Johan Van Hove, MD, PhD
Source: National Institutes of Health - U54 RR019455
Amount: $4,700,000
Term: 2004-2009

Pediatric General Clinical Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Director: William W. Hay, Jr., MD
Associate Program Director: Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: National Institutes of Health, National Center for Research Resources - MO1 RR00069
Amount: $16,884,197
Term: 2001-2006

Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005

Nutritional Etiology of Prediabetic Autoimmunity
Principal Investigator: Jill Norris, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - K0849654
Amount: $2,008,009
Term: 2001-2005

Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,595,198
Term: 1997-2006

Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 UO1-DK062453-01
Amount: $854,945
Term: 2002-2007

Third-Year Research Fellowship Award
Program Director: Ronald J. Sokol, MD
Fellow: Gregory E. Kobak, MD
Source: Cystic Fibrosis Foundation
Amount: $62,590
Term: 2002-2003

First- and Second-Year Clinical Fellowship Award
Program Director/Sponsor: Ronald J. Sokol, MD
Fellow: Elizabeth Utterson, MD
Source: Cystic Fibrosis Foundation - COLSON02BO
Amount: $42,000
Term: 2002-2003

A Preliminary Clinical Research Study on Antioxidant Therapy for Biliary Atresia in Infants and Children
Principal Investigator: Ronald J. Sokol, MD
Source: Madigan Foundation
Amount: $22,750
Term: 2003-2005

Postdoctoral Research Fellowship Grant
Program Director/Sponsor: Ronald J. Sokol, MD
Fellow: Gregory E. Kobak, MD
Source: American Liver Foundation
Amount: $10,000
Term: 2002-2003

Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: Fujisawa, Roche Laboratories
Amount: $4,000/yr
Term: 2004-2009

Head CT in the Evaluation of 1st Afebrile Seizures
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, Louis C. Hampers, MD, MBA, Carol Okada, MD, and Rebecca Fastle, MD
Term: 2000-2004

Postreduction Management of Intussusception
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, and Shayne Bland, MSc
Term: 2000-2002

Emergency Medical Services for Children Partnership Grant
Principal Investigator: F. Keith Battan, MD
Source: US Department of Health and Human Services, Maternal and Child Health Bureau -
FLAEMS01-00250
Amount: $122,000
Term: 2000-2001

L.O.C.O. (Latinos Overcoming Cultural Obstacles) "Needs Assessment for The Children's Hospital"
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001

The Truth about Language Barriers
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Stephen Federico, MD
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001-ongoing

Jungle Mobile: A Mobile Injury Prevention Project for Children
Principal Investigator: Kathryn D. Emery, MD
Co-Investigators: Allison Hawkes, MD, MS, Theresa Rapstine, RN, and Victoria Cassenbaugh, RN
Term: 1998-ongoing

A Screening Tool for the Detection of Child Abuse in the Emergency Department Setting
Joint Project with the Child Advocacy Protection Team

Principal Investigator: Kathryn D. Emery, MD
Term: 2001

Seat Belt and Car Safety Seat Use in SUVs
Primary Investigator: Kathryn D. Emery, MD
Co-Investigators: Lisa Hardin Van Bramer, MD, and Kevin Raines, MD
Source: National Highway Traffic Safety Administration - STNH22-01-H-05-257
Amount: $350,000
Term: 2001-2003

Childhood Injury Prevention Concerns of Migrant and Seasonal Farm Workers in Weld County
Principle Investigator: Kathryn D. Emery, MD
Co-Investigator: S. Glenn Faries, MD
Source: Colorado Injury Control Research Center
Amount: $15,000
Term: 2002-2003

Domestic Violence Policies in Pediatric Emergency Departments
Principle Investigator: Kathryn D. Emery, MD
Co-Investigators: Sheila Sullivan, MD, Andrew P. Sirotnak, MD, and Stephanie Stronks-Knapp, MD
Term: 2002-ongoing

Development of an Injury-Free Coalition for Kids
Principal Investigator: S. Glenn Faries, MD
Co-Investigator: Kathryn D. Emery, MD
Term: 2001-ongoing

Resident Education in the Emergency Department
Principal Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Need for Atropine for Emergent Pediatric Intubations
Principal Investigator: Rebecca Fastle, MD
Co-Investigator: Mark G. Roback, MD
Term: 1999-ongoing

Resuscitation Teaching at Primary Care Centers
Principal Investigator: Margaret Ferguson, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-ongoing

Utility of Anaerobic Blood Cultures in a Pediatric Emergency Department
Principal Investigator: Stephen Freedman, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2003

PEM Collaborative Research Committee, Cerebral Edema and DKA
Principal Investigator: Nicole Glaser, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-2001

Comparison of Oral Prednisone vs. Dexamethasone in Pediatric Asthma
Principal Investigator: Richard A. Greenberg, MD
Co-Investigators: Genie E. Roosevelt, MD, MPH, and Gwendolyn S. Kerby, MD
Term: 2002-ongoing

Peak Flow vs. Spirometry in Acute Asthma
Principal Investigator: David Gutglass, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 1997-ongoing

A.C.C.E.S.S. for Latinos: After-Hours Call Center and Extended Spanish Service
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: Lauren Clark, PhD, RN, and Stephen Berman, MD
Term: 2001-2002

The Impact of Interpreters on Resource Utilization in a Pediatric Emergency Department
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Jennifer McNulty, MD
Term: 1999-2002

Physician-Based Practice Pattern Variations in the Management of AGE
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Elizabeth Powell, MD, MPH
Term: 2001-ongoing

Practice Variation in the Management of Croup
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 1999-2002

Regional After-Hours Urgent Care Provided by a Tertiary Children's Hospital
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 2001-2002

Booster Seat Project
Principal Investigator: Lisa Hardin Van Bramer, MD
Co-Investigator: Kathryn D. Emery, MD
Source: Emergency Medical Services and Kiwanis Pediatric Trauma Institute
Amount: $18,000
Term: 2001-2002

Association of Influenza with Bacterial Tracheitis
Principal Investigator: Ron L. Kaplan, MD
Co-Investigators: Mark G. Roback, MD, and Peggy Kelly, MD
Term: 2002-ongoing

Safety, Tolerability and Efficacy Study of Levalbuterol and Racemic Albuterol in Pediatric Patients Birth to 48 Months Old with Reactive Airways Disease in an Acute Setting
Principal Investigator: Gwendolyn S. Kerby, MD
Co-Investigator: S. Glenn Faries, MD
Term: 2001-2002

Effect of Ondansetron on Ketamine Sedation-Associated Vomiting
Principal Investigator: William T. Langston, MD
Co-Investigators: Joseph E. Wathen, MD, and Mark G. Roback, MD
Source: The Children's Hospital Research Institute
Amount: $5,000
Term: 2002-ongoing

Effect of Medical Spanish Classes on Satisfaction of Hispanic Patients in Pediatric Emergency Department
Principal Investigator: Suzanne Mazor, MD
Co-Investigators: Vidya Chande, MD, Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 2000-2002

Interpretation of Traumatic Lumbar Punctures: Who Can Go Home?
Principal Investigator: Suzan Mazor, MD
Co-Investigators: Jennifer McNulty, MD, and Genie E. Roosevelt, MD, MPH
Term: 2001-ongoing

How Is Emergency Department Decision-Making Affected by the Existence of Reliable Follow-Up?
Principal Investigator: Jennifer McNulty, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 1999-2001

Decision Rules for Obtaining Radiographs in Pediatric Knee Injuries
Principal Investigator: Brian Moore, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Kathryn Emery, MD
Term: 1998-ongoing

Indications for Knee Radiographs in Pediatric Patients with Acute Knee Injuries/Validation of a Clinical Decision Rule
Principal Investigator: Brian Moore, MD
Co-Investigators: Carol Turner, MD, and Kathryn D. Emery, MD
Term: 2000-ongoing

Correlation of Hemolysis with Facticous Hyperkalemia
Principal Investigator: Heather Owens, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Acute Complication of Type 1 Diabetes in Children
Primary Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Mark G. Roback, MD, and Joan P. Bothner, MD
Term: 2001-ongoing

Childhood Pedestrian Injuries
Primary Investigator: Arleta B. Rewers, MD, PhD
Term: 2002-ongoing

Femur Fractures and Associated Injuries
Principal Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Kathryn D. Emery, MD, and F. Keith Battan, MD
Term: 2000-ongoing

Are Chest X-Rays Required for all First-Time Wheezers?
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Mark E. Anderson, MD, and John D. Strain, MD
Term: 1998-ongoing

Comparison of the Efficacy and Safety of Sedation Drugs Used in a Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Joseph E. Wathen, MD, and Joan P. Bothner, MD
Term: 1999-ongoing

IV vs. IM Ketamine Sedation in the Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Joseph E. Wathen, MD
Source: The Children's Hospital Research Institute
Amount: $35,000
Term: 2000-ongoing

Pediatric Resuscitation Practice and Success Rate
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Rebecca Fastle, MD
Term: 2000-ongoing

Predictors of Which Patients will Benefit from Observations vs. Hospital Admission
Principal Investigator: Genie E. Roosevelt, MD, MPH
Co-Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Randomized, Double-Blind Study of Intravenous Fluids With and Without Dextrose in the Treatment of Dehydration in Pediatric Patients with Vomiting and Ketosis
Principal Investigator: Genie E. Roosevelt, MD, MPH
Term: 2002-ongoing

The Effect of Dehydration on the QT Interval of Healthy Children
Principal Investigator: Carl Shaw, MD
Co-Investigators: Joseph E. Wathen, MD, and Michael S. Schaffer, MD
Term: 2001

The Prevalence of Urinary Tract Infections in Febrile Children with AGE
Principal Investigator: Carl Shaw, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Use of Complementary Medicine in Pediatric Patients with Asthma
Principal Investigator: Alison Siegel Tothy, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2002

Associations between Insurance Type and Pediatric Admission Rate in Colorado, 1993-1999: Is Managed Care Fulfilling Its Promise?
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and James K. Todd, MD
Term: 2000-ongoing

Associations of Parental Depression and Child Health Outcomes
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Allison Kempe, MD, John Steiner, MD, David Price, MD, and David Magid, MD
Term: 2002-ongoing

Comparison of the Longitudinal Marginal Cost, Morbidity and Mortality of Inflicted and Unintentional Head Injuries in Young Children in a Nationwide Sample of Children's Hospitals
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Costs of Childhood Physical Abuse: Comparing Inflicted and Unintentional Head Injuries in Colorado Inpatients Under Three Years Old
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Epidemiology of Pediatric Psychiatric Visits to US Emergency Departments, Based on the National Hospital Ambulatory Medical Care Survey 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Hospital-Level Predictors of Inefficiency Amongst Hospitalized Patients in New York State
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and Andrew Racine, MD, PhD
Term: 2000-ongoing

Management of Acute Gastroenteritis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Management of Bronchiolitis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1993-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Comparison of Fascia Iliaca Compartment Nerve Block to Traditional Systemic Analgesics for Femur Fractures in a Pediatric Emergency Department
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Glen Merritt, MD, Gaia Georgopoulos, MD, and F. Keith Battan, MD
Source: The Children's Hospital Research Institute
Amount: $17,594
Term: 2001-2004

Pediatric EKG Interpretation Accuracy by Pediatric Emergency Medicine Physicians
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Arleta Rewers, MD, PhD, Angela Yetman MD, and Michael Schaffer MD
Term: 2001-ongoing

A Randomized Trial of Telephonic vs. On-Site Language Interpretation in a Pediatric ED
Principal Investigator: Ethan S. Wiener, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing